论文部分内容阅读
虽然n-3多价不饱和脂肪酸(PUFAs)治疗冠心病有明显的效果,但它用于治疗其他心血管病的效果仍存在着争议,作为一种始终可靠的药物治疗,仍存在着很大的障碍。用于其他心血管病的最大障碍是其分子机制及贴切的计量尚未明确。
Although n-3 polyunsaturated fatty acids (PUFAs) have shown significant efficacy in the treatment of coronary heart disease, the efficacy of n-3 polyunsaturated fatty acids (PUFAs) in the treatment of other cardiovascular diseases remains controversial and as a consistent and reliable drug treatment, Barrier. The biggest obstacle to other CVDs is its molecular mechanism and the appropriate measurement is not yet clear.